Kenilworth, NJ, February 15, 2008 --(PR.com
)-- Schering-Plough Animal Health Corporation has announced the release of Ultra Saber, a new pour-on insecticide that controls horn flies on beef cattle and calves. Ultra Saber is a new type of pour-on insecticide that contains 1 percent lambdacyhalothrin and 5 percent piperonyl butoxide, a synergist which improves insecticidal activity.
“The horn fly is one of the most significant and economically destructive external parasites in pastured cattle today, causing animal blood loss, reduced feed efficiency and weight gain and lower milk production,” said Norm Stewart, DVM, Technical Services Veterinarian, Schering-Plough Animal Health Corp. “It is estimated that horn flies cause the U.S. cattle industry $730 million in lost production annually.”
Field trial results show new Ultra Saber was the most effective treatment for reducing initial and subsequent horn fly populations during the eight-week trial period.
“Older fly control products may lose efficacy over time and cattle producers are in need of new, more effective fly control products. Ultra Saber is a highly efficacious combination of insecticide and synergist. This unique combination results in increased insecticidal activity and is another tool in the Schering-Plough ectoparasiticide portfolio of products designed to meet this growing need for more effective fly control,” Stewart said.
The product also controls lice in beef cattle and calves. Lice infestations, which peak in late winter, cause reduced average daily gains. Infested cows also produce less milk for their calves.
Ultra Saber is available now through animal health suppliers nationwide.
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. In November 2007, Schering-Plough acquired Organon BioSciences, with its Organon human health and Intervet animal health businesses, marking a pivotal step in the company's ongoing transformation. Schering-Plough’s vision is to “Earn Trust, Every Day” with the doctors, patients, customers and other stakeholders served by its approximately 50,000 people around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.